Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))

Guadalupe Miró, Christine Petersen, Luís Cardoso, Patrick Bourdeau, Gad Baneth, Laia Solano-Gallego, Maria Grazia Pennisi, Lluís Ferrer, Gaetano Oliva

Research output: Contribution to journalComment/debate

4 Scopus citations

Abstract

The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.

Original languageEnglish
Pages (from-to)445
Number of pages1
JournalTrends in Parasitology
Volume34
Issue number5
DOIs
StatePublished - May 2018

Bibliographical note

Publisher Copyright:
© 2017 Elsevier Ltd

Fingerprint

Dive into the research topics of 'Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))'. Together they form a unique fingerprint.

Cite this